Topic Editors

Centre Tisp, Istituto Superiore Di Sanita, 000161 Rome, Italy
Department of Electronic Engineering, University of Rome Tor Vergata, 00133 Rome, Italy

Artificial Intelligence in Public Health: Current Trends and Future Possibilities, 2nd Edition

Abstract submission deadline
31 October 2025
Manuscript submission deadline
31 December 2025
Viewed by
5335

Topic Information

Dear Colleagues,

Due to the COVID-19 pandemic, we are witnessing a growing scientific interest in the development and application of artificial intelligence in the health domain. Research in this area is strategic for the development of health systems and is inextricably linked to the development of digital health, both as regards the collection, -monitoring and management of information, and as regards the management of hospital and connected government information systems. Think, for example, of the opportunities presented by wearable monitoring, big data, and robotic surgery. The applications of artificial intelligence have received growing interest in many sectors, such as: organ, functional tissue and cell diagnostics; care robotics, assisting in interventions, rehabilitation and supporting the communication and assistance of disabled people; the biomedicine sector, from genetics to modeling; and precision and personalized biomedicine.

A statement by Henry Ford reported that "real progress happens only when the advantages of a new technology become available to everybody".

The consolidation of technologies based on artificial intelligence in the health domain is intended to bring benefits to everyone, from the stakeholder to the patient, in the form of equity of care.

Artificial intelligence in the future will have a strong impact on:

  • The prevention of the onset of diseases in the individual and in society
  • The provision of personal care and assistance.
  • Society trends regarding diseases and the impact of biological and behavioral factors.
  • Organization of hospital activities with regard to treatment, diagnostic and decision-making processes.

Thanks to artificial intelligence, on the one hand, big data will help us to predict diseases on an individual and collective basis and to identify and correct population behaviors; on the other hand, wearable technologies will allow us to monitor and collect individual medical information and to calibrate the care process. The integration of artificial intelligence with virtual reality and augmented reality will allow us to create both virtual medicine services that citizens can access in a simple and direct way, and robotic surgery applications that are increasingly effective and safe.

This topic is very broad, and ranges from scientific development to applications in the health domain, and it also includes ethical and training issues.

This Topic invites authors to contribute on aspects of the research on, development, and application of artificial intelligence in current applications in the health domain and in future scenarios of use.

In this Topic, original research articles, reviews, commentaries, opinions, viewpoints, communications and brief reports are welcome. Research areas may include (but are not limited to) the following:

  • Artificial neural networks
  • Deep learning
  • Care robotics
  • Natural language processing
  • Social intelligence
  • Virtual reality
  • Augmented reality
  • Medical decision making
  • Disease monitoring, prediction, diagnosis, and classification
  • Patient monitoring
  • Hospital organization
  • Diagnostic imaging
  • Digital pathology
  • Digital radiology.

We look forward to receiving your contributions.

Prof. Dr. Daniele Giansanti
Dr. Giovanni Costantini
Topic Editors

Keywords

  • artificial intelligence
  • neural networks
  • big data
  • robotics
  • healthcare
  • virtual reality
  • augmented reality
  • digital health
  • digital radiology
  • digital pathology

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
AI
ai
5.0 6.9 2020 20.7 Days CHF 1600 Submit
Applied Sciences
applsci
2.5 5.5 2011 19.8 Days CHF 2400 Submit
Bioengineering
bioengineering
3.7 5.3 2014 19.2 Days CHF 2700 Submit
Healthcare
healthcare
2.7 4.7 2013 21.5 Days CHF 2700 Submit
International Journal of Environmental Research and Public Health
ijerph
- 8.5 2004 27.8 Days CHF 2500 Submit
Journal of Clinical Medicine
jcm
2.9 5.2 2012 17.7 Days CHF 2600 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (5 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
13 pages, 1126 KiB  
Article
ChatGPT in the Management of Chronic Rhinosinusitis with Nasal Polyps: Promising Support or Digital Illusion? Insights from a Multicenter Observational Study
by Riccardo Manzella, Angelo Immordino, Cosimo Galletti, Federica Giammona Indaco, Giovanna Stilo, Giuliano Messina, Francesco Lorusso, Rosalia Gargano, Silvia Frangipane, Giorgia Giunta, Diana Mariut, Daniele Portelli, Patrizia Zambito, Maria Grazia Ferrisi, Francesco Ciodaro, Manuela Centineo, Salvatore Maira, Francesco Dispenza, Salvatore Gallina, Ignazio La Mantia, Francesco Galletti, Bruno Galletti and Federico Sireciadd Show full author list remove Hide full author list
J. Clin. Med. 2025, 14(13), 4501; https://doi.org/10.3390/jcm14134501 - 25 Jun 2025
Viewed by 235
Abstract
Background/Objective: Chronic rhinosinusitis with nasal polyps is a chronic inflammatory disease with a significant impact on quality of life and is frequently associated, from a pathogenetic perspective, with type 2 inflammation. The introduction of biologic therapies has marked a turning point in the [...] Read more.
Background/Objective: Chronic rhinosinusitis with nasal polyps is a chronic inflammatory disease with a significant impact on quality of life and is frequently associated, from a pathogenetic perspective, with type 2 inflammation. The introduction of biologic therapies has marked a turning point in the management of severe forms of the disease, offering a valuable treatment option. However, selecting the most suitable biologic agent for a specific patient remains a clinical challenge. Artificial intelligence, and, in particular, ChatGPT, has recently been proposed as a potential tool to support medical decision-making and guide therapeutic choices. To evaluate the concordance between the therapeutic recommendations provided by ChatGPT and those of a multidisciplinary expert board in selecting the most appropriate biologic therapy for CRSwNP patients, based on the analysis of their phenotype and endotype. Methods: A multicenter observational cohort study was conducted. Clinical data from 286 patients with CRSwNP were analyzed. For each case, the therapeutic choice among Dupilumab, Mepolizumab, and Omalizumab was compared between the board and ChatGPT. Concordance rates and Cohen’s Kappa coefficient were calculated. Results: Overall concordance was 59.2%, with a Cohen’s Kappa coefficient of 0.116. Concordance by drug was 62.8% for Dupilumab, 26.5% for Mepolizumab, and 9.1% for Omalizumab. Patients presented with severe clinical profiles, with an average Nasal Polyp Score of 6.22 and an average SNOT-22 score of 64.5. Conclusions: This study demonstrates that, despite its substantial theoretical potential, ChatGPT is currently not a reliable tool for the autonomous selection of biological therapies in patients with CRSwNP. Further studies are necessary to enhance its reliability and integration into clinical practice. Full article
Show Figures

Figure 1

10 pages, 402 KiB  
Article
Using Machine Learning to Predict Resilience Among Nurses in a South African Setting
by Jennifer Chipps, Amanda Cromhout and Umit Tokac
Int. J. Environ. Res. Public Health 2025, 22(7), 996; https://doi.org/10.3390/ijerph22070996 (registering DOI) - 24 Jun 2025
Viewed by 119
Abstract
Nursing is a stressful profession. Stress can affect the mental health of nurses. A positive response to stress, resilience, is known to be a protective factor against mental health issues. This study aimed to use machine learning with secondary data from five survey [...] Read more.
Nursing is a stressful profession. Stress can affect the mental health of nurses. A positive response to stress, resilience, is known to be a protective factor against mental health issues. This study aimed to use machine learning with secondary data from five survey studies, conducted between 2022 and 2023, to identify factors predicting high versus low levels of resilience in South African nursing samples from the Western Cape Province, South Africa. The sample included (1134 records (male = 250, 22.0%, female = 874, 77.1%, and other = 10 (0.9%) included all data on all categories of nursing staff (student nurses (567, 50%), professional registered nurses (315, 27.8%), and non-professional nurses (246, 21.7%) who completed a survey using a response to stress scale. We used random forest analysis, demographic variables, years of experience, and a brief 4-item screen of resilience to predict resilience. The model yielded limited added value from demographic groupings in this model, but the brief screening had an overall classification accuracy of 86.41% (95% CI: 0.810; 0.908). Full article
Show Figures

Figure 1

40 pages, 1816 KiB  
Review
Exploring the Potential of Digital Twins in Cancer Treatment: A Narrative Review of Reviews
by Daniele Giansanti and Sandra Morelli
J. Clin. Med. 2025, 14(10), 3574; https://doi.org/10.3390/jcm14103574 - 20 May 2025
Viewed by 944
Abstract
Background: Digital twin (DT) technology, integrated with artificial intelligence (AI) and machine learning (ML), holds significant potential to transform oncology care. By creating dynamic virtual replicas of patients, DTs allow clinicians to simulate disease progression and treatment responses, offering a personalized approach to [...] Read more.
Background: Digital twin (DT) technology, integrated with artificial intelligence (AI) and machine learning (ML), holds significant potential to transform oncology care. By creating dynamic virtual replicas of patients, DTs allow clinicians to simulate disease progression and treatment responses, offering a personalized approach to cancer treatment. Aim: This narrative review aimed to synthesize existing review studies on the application of digital twins in oncology, focusing on their potential benefits, challenges, and ethical considerations. Methods: The narrative review of reviews (NRR) followed a structured selection process using a standardized checklist. Searches were conducted in PubMed and Scopus with a predefined query on digital twins in oncology. Reviews were prioritized based on their synthesis of prior studies, with a focus on digital twins in oncology. Studies were evaluated using quality parameters (clear rationale, research design, methodology, results, conclusions, and conflict disclosure). Only studies with scores above a prefixed threshold and disclosed conflicts of interest were included in the final synthesis; seventeen studies were selected. Results and Discussion: DTs in oncology offer advantages such as enhanced decision-making, optimized treatment regimens, and improved clinical trial design. Moreover, economic forecasts suggest that the integration of digital twins into healthcare systems may significantly reduce treatment costs and drive growth in the precision medicine market. However, challenges include data integration issues, the complexity of biological modeling, and the need for robust computational resources. A comparison to cutting-edge research studies contributes to this direction and confirms also that ethical and legal considerations, particularly concerning AI, data privacy, and accountability, remain significant barriers. Conclusions: The integration of digital twins in oncology holds great promise, but requires careful attention to ethical, legal, and operational challenges. Multidisciplinary efforts, supported by evolving regulatory frameworks like those in the EU, are essential for ensuring responsible and effective implementation to improve patient outcomes. Full article
Show Figures

Figure 1

13 pages, 1649 KiB  
Article
Impact of the COVID-19 Pandemic on Life Expectancy in South Korea, 2019–2022
by Soojin Song and Daroh Lim
Healthcare 2025, 13(3), 258; https://doi.org/10.3390/healthcare13030258 - 28 Jan 2025
Cited by 2 | Viewed by 1046
Abstract
Objective: This study investigated changes in life expectancy due to the COVID-19 pandemic by analyzing the contributions of age, sex, and cause of death in 2019 and 2022. Methods: Korea’s simplified life table and cause-of-death statistics from 2019 to 2022 were used to [...] Read more.
Objective: This study investigated changes in life expectancy due to the COVID-19 pandemic by analyzing the contributions of age, sex, and cause of death in 2019 and 2022. Methods: Korea’s simplified life table and cause-of-death statistics from 2019 to 2022 were used to assess mortality changes by age, sex, and cause of death during the pandemic. Joinpoint regression analysis was applied to detect trends, and the Arriaga decomposition method was used to quantify the contributions of age, sex, and cause of death to life expectancy changes. Results: Joinpoint regression identified a slow increase in life expectancy in 2007 and a decline in 2020, coinciding with the COVID-19 pandemic. Life expectancy decreased markedly for men (−0.36 years per year, 95%CI: −0.68 to −0.03) and women (−0.45 years per year, 95%CI: −0.71 to −0.18). Age-specific contributions revealed declines across age groups, with the steepest reductions in the older population (80 years or older: −0.35 years for men; −0.52 years for women). Women (−0.68 years) contributed more to the decline in life expectancy than men (−0.41 years). COVID-19 ranked as the third leading cause of death in 2022, significantly contributing to the decline in life expectancy among the older population (aged 80 years or older: −0.306 years for men, −0.408 years for women). Women in Korea were more affected than men, reducing the sex-specific gap in life expectancy by 0.3 years. Conclusions: The COVID-19 pandemic significantly impacted the life expectancy in Korea, particularly among older adults, with women experiencing a greater decline than men. These findings emphasize the need for targeted public health strategies to address age and sex disparities in future pandemics. Before the pandemic, non-communicable diseases such as malignant neoplasms, heart disease, and cerebrovascular disease dominated Korea’s top 10 causes of death. During the pandemic, however, COVID-19 rose to third place by 2022. Notably, intentional self-harm (suicide) contributed to an increase in life expectancy, suggesting shifts in the relative impact of various causes of death. Full article
Show Figures

Figure 1

24 pages, 1499 KiB  
Article
Explainable Artificial Intelligence for Predicting Attention Deficit Hyperactivity Disorder in Children and Adults
by Zineb Namasse, Mohamed Tabaa, Zineb Hidila and Samar Mouchawrab
Healthcare 2025, 13(2), 155; https://doi.org/10.3390/healthcare13020155 - 15 Jan 2025
Viewed by 1919
Abstract
Attention Deficit Hyperactivity Disorder (ADHD) is a disorder that starts in childhood, sometimes persisting into adulthood. It puts a strain on their social, professional, family, and environmental lives, which can exacerbate disorders such as anxiety, depression, and bipolar disorder. Background/Objectives: This paper [...] Read more.
Attention Deficit Hyperactivity Disorder (ADHD) is a disorder that starts in childhood, sometimes persisting into adulthood. It puts a strain on their social, professional, family, and environmental lives, which can exacerbate disorders such as anxiety, depression, and bipolar disorder. Background/Objectives: This paper aims to predict ADHD in children and adults and explain the main factors impacting this disorder. Methods: We start by introducing the main symptoms and challenges ADHD poses for children and adults such as epilepsy and depression. Then, we present the results of existing research on three ADHD comorbidities: anxiety, depression, and bipolar disorder, and their possible continuity in adulthood with therapeutic implications. After that, we explain the impact of this disorder and its relationship with these comorbidities on the affected patient’s health and environment and list proposed treatments. We propose a methodology for predicting this impairment in children and adults by using Machine Learning algorithms (ML), Explainable Artificial Intelligence (XAI), and two datasets, the National Survey for Children’s Health (NSCH) (2022) for the children and the ADHD|Mental Health for the adults. Results: Logistic Regression (LR) was the most suitable algorithm for children, with an accuracy of 99%. As for adults, the XGBoost (XGB) was the most performant ML method, with an accuracy of 100%. Conclusions: Lack of sleep and excessive smiling/laughing are among the factors having an impact on ADHD for children, whereas anxiety and depression affect ADHD adults. Full article
Show Figures

Figure 1

Back to TopTop